Underhill Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-42,110
Closed -$4.61M 20
2017
Q4
$4.61M Sell
42,110
-350
-0.8% -$34.9K 2.2% 15
2017
Q3
$4.19M Sell
42,460
-15,935
-27% -$1.54M 2.27% 15
2017
Q2
$5.91M Sell
58,395
-18,725
-24% -$2.02M 3.74% 12
2017
Q1
$8.91M Sell
77,120
-5,650
-7% -$657K 5.7% 11
2016
Q4
$9.94M Sell
82,770
-5,610
-6% -$621K 5.76% 8
2016
Q3
$9.93M Sell
88,380
-3,950
-4% -$455K 5.49% 9
2016
Q2
$11.4M Sell
92,330
-2,450
-3% -$296K 6.17% 8
2016
Q1
$10.7M Sell
94,780
-34,625
-27% -$3.6M 5.37% 10
2015
Q4
$14.1M Sell
129,405
-2,800
-2% -$321K 7.6% 8
2015
Q3
$13.2M Buy
132,205
+1,400
+1% +$152K 6.5% 10
2015
Q2
$14.9M Sell
130,805
-500
-0.4% -$60.6K 7.08% 10
2015
Q1
$13.7M Buy
+131,305
New +$14M 6.8% 10

Other funds holding CLB

Underhill Investment Management's CLB Position: Q1 2018 in Review

Underhill Investment Management sold out of Core Laboratories (CLB) in Q1 2018, closing a stake of 42,110 shares — an estimated $4.61M sold.

Underhill Investment Management first reported a position in CLB in Q1 2015 and held it in 12 quarters. The position peaked at $14.9M in Q2 2015. 355 funds tracked by Wall St. Rank hold CLB as of Q1 2018.

  • Underhill Investment Management reported no remaining Core Laboratories position as of Q1 2018 after selling out during the quarter.
  • Underhill Investment Management sold 42,110 Core Laboratories shares in Q1 2018, an estimated $4.61M.
  • Underhill Investment Management first reported a position in Core Laboratories in Q1 2015 and held it in 12 quarters.
  • Underhill Investment Management's Core Laboratories position peaked at $14.9M in Q2 2015.
  • 355 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2018.

Based on Underhill Investment Management's 13F filing for Q1 2018, filed 25 Apr 2018.